Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2006 1
2014 1
2017 1
2018 1
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.
Awad MM, Govindan R, Balogh KN, Spigel DR, Garon EB, Bushway ME, Poran A, Sheen JH, Kohler V, Esaulova E, Srouji J, Ramesh S, Vyasamneni R, Karki B, Sciuto TE, Sethi H, Dong JZ, Moles MA, Manson K, Rooney MS, Khondker ZS, DeMario M, Gaynor RB, Srinivasan L. Awad MM, et al. Cancer Cell. 2022 Sep 12;40(9):1010-1026.e11. doi: 10.1016/j.ccell.2022.08.003. Epub 2022 Aug 25. Cancer Cell. 2022. PMID: 36027916 Free article. Clinical Trial.
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, Margolin K, Awad MM, Hellmann MD, Lin JJ, Friedlander T, Bushway ME, Balogh KN, Sciuto TE, Kohler V, Turnbull SJ, Besada R, Curran RR, Trapp B, Scherer J, Poran A, Harjanto D, Barthelme D, Ting YS, Dong JZ, Ware Y, Huang Y, Huang Z, Wanamaker A, Cleary LD, Moles MA, Manson K, Greshock J, Khondker ZS, Fritsch E, Rooney MS, DeMario M, Gaynor RB, Srinivasan L. Ott PA, et al. Cell. 2020 Oct 15;183(2):347-362.e24. doi: 10.1016/j.cell.2020.08.053. Cell. 2020. PMID: 33064988 Free article. Clinical Trial.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. Rosenblat JD, et al. Can J Psychiatry. 2023 Jan;68(1):5-21. doi: 10.1177/07067437221111371. Epub 2022 Aug 17. Can J Psychiatry. 2023. PMID: 35975555 Free PMC article. Review.
Adverse events associated with psychedelics, including psychological (e.g., psychotomimetic effects) and physical (e.g., nausea, emesis and headaches) effects, were generally transient. ...
Adverse events associated with psychedelics, including psychological (e.g., psychotomimetic effects) and physical (e.g., nause …
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
Hussain M, Daignault-Newton S, Twardowski PW, Albany C, Stein MN, Kunju LP, Siddiqui J, Wu YM, Robinson D, Lonigro RJ, Cao X, Tomlins SA, Mehra R, Cooney KA, Montgomery B, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, Smith DC, Caram MV, Knudsen KE, Stadler WM, Feng FY, Chinnaiyan AM. Hussain M, et al. J Clin Oncol. 2018 Apr 1;36(10):991-999. doi: 10.1200/JCO.2017.75.7310. Epub 2017 Dec 20. J Clin Oncol. 2018. PMID: 29261439 Free PMC article. Clinical Trial.
Results A total of 148 patients with mCRPC were randomly assigned: arm A, n = 72; arm B, n = 76. There were no differences in PSA RR (63.9% v 72.4%; P = .27), mRR (45.0% v 52.2%; P = .51), or median PFS (10.1 v 11 months; P = .99). ...Median PFS was lo …
Results A total of 148 patients with mCRPC were randomly assigned: arm A, n = 72; arm B, n = 76. There were no differences in PSA RR …
Cardiovascular risk and events in 17 low-, middle-, and high-income countries.
Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators. Yusuf S, et al. N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890. N Engl J Med. 2014. PMID: 25162888 Free article.
Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
ICMR COVID Study Group (In alphabetical order: Priya Abraham†, Neeraj Aggarwa l2, Giridhara R. Babu 7, Suganya Barani 8, Balram Bhargava 4, Tarun Bhatnagar 8, Ajay Singh Dhama 3, Raman R. Gangakhedkar 2, Sidhartha Giri 2, Nivedita Gupta 2, Karishma K. Kurup 5, Ponnaiah Manickam 9, Manoj Murhekar ††, Varsha Potdar 1, Ira Praharaj 2, Kiran Rade 6, D.C.S. Reddy 11, V. Saravanakumar 10, Naman Shah 12, Harpreet Singh 3, Jeromie Wesley Vivian Thangaraj 8, Naveen Yadav 8), COVID Epidemiology & Data Management Team @, COVID Laboratory Team*, VRDLN Team$; @COVID Epidemiology & Data Management Team (in alphabetical order): Tanu Anand, Harish Kumar Butollia, Pranab Chatterjee, Himanshu Chauhan, R Deepa, Amirthammal Gunasekaran, Daisy A John, Shashi Kant, Sanket Kulkarni, Vinit Kumar, JP Muliyil, Ravindra Mohan Pandey, Swarup Sarkar, Sujeet Singh, Sanjay Zodpey; *COVID Laboratory Team (in alphabetical order): Srima Adhikari, Jyotsna Agarwal, Naveen KumarAgarwal, Saurabh G Agarwal, Prerna Aggarwal, Anurag Agrawal, Arti Agrawal, Safaa Muneer Ahmed, G Ambernath, Nitin Ambhore, VP Amudha, Sohini Arora, Ashok, Anita, Awanti, Veer Badriyah TA, Amrita Kumari B, Maneesh Bagai, Dipa Baido, Bai… See abstract for full author list ➔ ICMR COVID Study Group (In alphabetical order: Priya Abraham†, Neeraj Aggarwa l2, Giridhara R. Babu 7, Suganya Barani 8, Balram Bhargava 4, Tarun Bhatnagar 8, Ajay Singh Dhama 3, Raman R. Gangakhedkar 2, Sidhartha Giri 2, Nivedita Gupta 2, Karishma K. Kurup 5, Ponnaiah Manickam 9, Manoj Murhekar ††, Varsha Potdar 1, Ira Praharaj 2, Kiran Rade 6, D.C.S. Reddy 11, V. Saravanakumar 10, Naman Shah 12, Harpreet Singh 3, Jeromie Wesley Vivian Thangaraj 8, Naveen Yadav 8), COVID Epidemiology & Data Management Team @, COVID Laboratory Team*, VRDLN Team$, et al. Indian J Med Res. 2020 May;151(5):424-437. doi: 10.4103/ijmr.IJMR_1896_20. Indian J Med Res. 2020. PMID: 32611914 Free PMC article.
INTERPRETATION & CONCLUSIONS: The coverage and frequency of ICMR's laboratory surveillance for SARS-CoV-2 improved over time. COVID-19 was reported from most parts of India, and the attack rate was more among men and the elderly and common among close contacts. ...
INTERPRETATION & CONCLUSIONS: The coverage and frequency of ICMR's laboratory surveillance for SARS-CoV-2 improved over time. COV …
Aqueous spectroscopy and redox properties of carboxylate-bound titanium.
Uppal R, Incarvito CD, Lakshmi KV, Valentine AM. Uppal R, et al. Inorg Chem. 2006 Feb 20;45(4):1795-804. doi: 10.1021/ic051714j. Inorg Chem. 2006. PMID: 16471996
Analogous speciation behavior is suggested from the EPR spectroscopy of Ti(III) citrate aqueous solutions. The g tensors are deduced for several pH-dependent species from the simulated data. ...Complex 3 crystallizes in a monoclinic P2(1)/c space group with a = 9.5088(19) …
Analogous speciation behavior is suggested from the EPR spectroscopy of Ti(III) citrate aqueous solutions. The g tensors are deduced …
Structure of lansimide 2, a product from Clausena lansium.
Ji X, van der Helm D, Lakshmi V, Agarwal SK, Kapil RS. Ji X, et al. Acta Crystallogr C. 1992 Jun 15;48 ( Pt 6):1082-5. doi: 10.1107/s0108270191013276. Acta Crystallogr C. 1992. PMID: 1388941
The mixture crystallizes as a molecular pair in the centrosymmetric space group P21/n. M(r) = 576.69, monoclinic, a = 20.151 (2), b = 6.2984 (4), c = 24.051 (2) A, beta = 104.339 (8) degrees, V = 2957.4 A3, Z = 4, Dx = 1.30 g cm-3, Cu K alpha, lambda = 1.5417 …
The mixture crystallizes as a molecular pair in the centrosymmetric space group P21/n. M(r) = 576.69, monoclinic, a = 20.151 (2), b = …